Chanelle Pharma

Chanelle Pharma is a well-established, privately-held Irish company and a significant global player in the generic pharmaceuticals space, uniquely spanning both human and animal health. With over 35 years of operation, it has built a robust portfolio supported by over 4,500 product licenses worldwide, a substantial manufacturing footprint, and dedicated R&D capabilities. The company is executing a clear growth strategy, evidenced by recent high-profile executive appointments and a strategic technology partnership with SAP, positioning it for further international expansion.

Integrated generic pharmaceutical development and manufacturing platform for solid, liquid, and semi-solid dosage forms, supported by five R&D labs and a recent strategic digital transformation partnership with SAP.

Operates in the highly competitive global generic pharmaceuticals manufacturing sector, competing with large Indian and European CDMOs and generic manufacturers. In animal health, competes with other veterinary generic producers and the manufacturing divisions of large animal health companies. Its differentiation lies in its combined human/animal health expertise, integrated R&D, and strategic European base.